Lundbeck has released its report for the first three months of 2022, which reveals revenue and EBIT (earnings before interest and taxes) results that exceed the analyst consensus estimates.
Analysts had predicted an EBIT result of DKK 731m (USD 103.7m), which Lundbeck exceeded with a result of DKK 875m (USD 124m). Revenue was predicted to land at DKK 4.2bn (USD 600m) by analysts, but totaled DKK 4.4bn (USD 620m) for the period.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
WS Audiology brings in head of EMEA region from Coloplast
The hearing aid manufacturer has appointed Coloplast’s now outgoing president for emerging markets as president for the EMEA region.
Dupixent could dominate pediatric eczema market for up to a decade, analysis finds
Sanofi and Regeneron will be able to call themselves market leaders within atopic eczema treatment for children aged 6 months to 5 for years to come, according to Globaldata.
FDA advisors support approval for Ferring's intestinal infection medicine
All signs indicate that Ferring Pharmaceuticals is on the cusp of being market authorized for its biologic candidate against C. difficile infection.
Pharmacosmos expects massive growth in four years
The company’s new chief executive has ambitions of reaching a DKK 2.5bn (USD 325m) revenue within the time frame.
The Lundbeck Foundation, ATP, LEGO asset manager join forces on secretive project
Three of Denmark’s biggest funds have come together for a yet unknown project, which includes the establishment of three new firms.
Lab Manager 
Drug Safety Associate 
KLIFO is looking for a Compliance Coordinator for our Glostrup office 
Sales Manager Denmark 
Senior Drug Product Specialist 
Senior/lead consultant at Emendo Engineering 
Pharmacovigilance & Regulatory Officer 
Head of Commercial / Sales Manager, Denmark 
Experienced IT Business Solutions Manager for the Danish Medicines Agency 
Product specialist 
Senior CMC Regulatory Manager 
Chief Business Officer 
Clinical Project Lead 
Senior Clinical Research Scientist 
Vice President, Medical Affairs 
Manager of QA, BHS Logistics